Qualcomm Incorporated (NASDAQ:QCOM) is increasingly focused on the premium smartphone market, where consumers tend to have greater purchasing power. On September 22, it unveiled Android phone chipsets specifically designed for on-device artificial intelligence.
Investor sentiment around AI remains an important part of the broader investment backdrop. Brad Gerstner recently argued that the latest negativity around AI is more political than fundamental and highlighted two new AI stock picks. Read more: Brad Gerstner Says Latest Negativity Around AI Is Political. See His 2 New AI Stock Picks.
Snapdragon 8 Elite Gen 6 and Snapdragon 8 Elite Extreme Gen 6 are the company’s two new mobile platforms. The platforms are designed to handle increasingly sophisticated on-device artificial intelligence workloads.
The chipsets are designed for the next generation of premium mobile devices, with advancements across AI, gaming, camera, and connectivity. The platforms could help Qualcomm strengthen its position across premium Android manufacturers and defend its handset business as on-device AI becomes a bigger feature of flagship smartphones.
AI Could Increase Qualcomm’s Silicon Content
Because the two platforms are designed for personalized AI, Qualcomm Incorporated can capture value as AI becomes a bigger differentiator in premium smartphones. Wider adoption could support the company’s premium handset semiconductor business by increasing the number of flagship designs using the technology and potentially raising the value of its content per high-end device.
Source:Pexels
While delivering agentic AI experiences, the new flagship mobile platforms could strengthen Qualcomm’s position in the premium Android AI-phone cycle. If Qualcomm makes its chips the computing platform for increasingly sophisticated on-device AI, it could increase their value in flagship phones.
Key Risks
While the new mobile platforms could strengthen the company’s premium handset footprint, it still has to contend with stiff competition. MediaTek has already transitioned to a 2nm flagship platform as Apple and Samsung continue to develop increasingly capable in-house silicon.
Apple and Samsung’s increasing shift to in-house modems and broader vertical integration by Apple and Samsung could reduce demand for Qualcomm Incorporated products. This is a significant problem because the two companies are key players in the premium devices market.
Even as the company pursues opportunities in the premium devices market, the broader smartphone semiconductor market has been contracting. Longer replacement cycles and higher component costs could make consumers delay upgrades, therefore affecting demand for the company’s advanced chipsets.
Hedge Fund Positioning
The Insider Monkey database indicates institutional positioning around Qualcomm Incorporated has been building as the company pursues opportunities around premium mobile devices. The number of hedge funds holding stakes in the company rose to 95 in the second quarter, up from 71 in the first quarter. Meanwhile, Marshall Wace LLP increased its stake in the company by 10157% to $458.68 million, as Altimeter Capital Management initiated a position worth $ 347.86 million.
Meanwhile, the number of QCOM shares held short increased to 38.32 million as of September 15 from 33.27 million as of August 14, representing 3.59% of the public float and low bearish positioning.
The Verdict
Qualcomm Incorporated’s new chipsets reinforce the strategy of targeting the premium smartphone market while expanding its role in the emerging on-device AI ecosystem. The opportunity extends beyond faster smartphone processors.
As AI becomes a more important feature of flagship devices, it could benefit from supplying the computing platform needed to run increasingly sophisticated AI applications directly on smartphones. However, competition and the growing use of internally developed silicon pose significant risks.
Qualcomm’s ability to maintain premium handset share and translate the growing demand for on-device AI into higher semiconductor content will be key factors to watch.
READ NEXT: Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership and Tigress Raises Alphabet (GOOGL) Price Target to $485 as AI Fuels Growth. Can the Momentum Last?.
Hedge Fund Resource Center